ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

ACS Funds $54 Million in Grants

June 28, 2002

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

Hawaii Gets CBCCP Award

August 12, 1977

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014